Skip to main content
. Author manuscript; available in PMC: 2024 Apr 12.
Published in final edited form as: J Psychopharmacol. 2017 Feb 15;31(4):434–441. doi: 10.1177/0269881117691590

Table 4.

Effects of AVL-3288 on the P50 auditory evoked response to repeated stimuli as change from baseline

Non-smokers S1 response ms S1 response mmv S2 response mmv P50 Ratio S2/S1
3 mg mean −8.83 0.30 0.41 0.02
sd 10.30 2.55 1.02 0.32
10 mg mean 0.50 0.30 0.00 −0.25
sd 2.26 1.07 1.92 0.79
30 mg mean 0.83 −0.17 −0.32 −0.18
sd 6.62 1.01 0.60 0.20
Placebo mean 1.67 0.01 0.42 0.10
sd 2.34 1.06 1.33 0.39
Smokers
3 mg mean −3.17 −0.50 −0.19 0.02
sd 8.28 0.54 0.68 0.42
Placebo mean 1.50 −0.40 −0.79 −0.23
sd 0.71 0.76 0.65 0.11